Xiaoliang Hua

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Nlrp Inflammasome

Top Venues

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoliang Hua, Jiong Zhang, Juan Chen, Rui Feng, Li Zhang, Xianguo Chen, Qing Jiang, Cheng Yang, Chao-Zhao Liang
Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway. The Prostate 84 (7) (2024)
Xiaoliang Hua, Jiong Zhang, Juan Chen, Rui Feng, Li Zhang, Xianguo Chen, Qing Jiang, Cheng Yang, Chao-Zhao Liang
Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway. The Prostate 84 (7) (2024)
Xiaoliang Hua, Jiong Zhang, Juan Chen, Rui Feng, Li Zhang, Xianguo Chen, Qing Jiang, Cheng Yang, Chao-Zhao Liang
Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway. The Prostate (2024)
Xiaoliang Hua, Jiong Zhang, Juan Chen, Rui Feng, Li Zhang, Xianguo Chen, Qing Jiang, Cheng Yang, Chao-Zhao Liang
Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway. The Prostate 84 (7) (2024)
Xiaoliang Hua, Shengdong Ge, Jiong Zhang, Haibing Xiao, Sheng Tai, Cheng Yang, Li Zhang, Chao-Zhao Liang
A costimulatory molecule-related signature in regard to evaluation of prognosis and immune features for clear cell renal cell carcinoma. Cell death discovery 7 (1) (2021)